Literature DB >> 3352655

Transient weakness and altered membrane characteristic in recessive generalized myotonia (Becker).

R Rüdel1, K Ricker, F Lehmann-Horn.   

Abstract

The isometric force of arm and leg muscles was studied in five unrelated patients with recessive generalized myotonia (Becker). The symptom of myotonia was present mainly in the legs, whereas transient weakness was the prominent symptom in the arms. Tocainide improved both symptoms, although it improved the stiffness more than the weakness. A specimen of intact muscle fibers was excised from the external intercostal muscle of one of the patients. The resting potential of the fibers was normal, but on injection of depolarizing current the fibers responded with repetitive action potentials. In normal interstitial fluid the current-voltage relationship was N-shaped, with a region of negative slope between -70 and -55 mV. Replacement of chloride by an impermeant anion changed this relationship very little, suggesting an abnormally small chloride conductance. The potassium current through the inward-going rectifier was larger than normal. The force of tetanic contractions of a rested bundle was not sustained but fell quickly to a plateau that increased with repeated stimulation. The relaxation of a rested tetanus was slow and accompanied by spontaneous electrical activity. In subsequent contractions the relaxation became faster and electrical after-activity decreased. However at 23 degrees C the speed of relaxation was always high despite a large amount of electrical after-activity. The electrical instability of the membrane and the transient weakness can be explained on the basis of the N-shaped membrane characteristic.

Entities:  

Mesh:

Year:  1988        PMID: 3352655     DOI: 10.1002/mus.880110303

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  9 in total

Review 1.  Diagnostics and therapy of muscle channelopathies--Guidelines of the Ulm Muscle Centre.

Authors:  F Lehmann-Horn; K Jurkat-Rott; R Rüdel
Journal:  Acta Myol       Date:  2008-12

2.  Evidence for genetic homogeneity in autosomal recessive generalised myotonia (Becker).

Authors:  M C Koch; K Ricker; M Otto; F Wolf; B Zoll; C Lorenz; K Steinmeyer; T J Jentsch
Journal:  J Med Genet       Date:  1993-11       Impact factor: 6.318

Review 3.  Channelopathies of skeletal muscle excitability.

Authors:  Stephen C Cannon
Journal:  Compr Physiol       Date:  2015-04       Impact factor: 9.090

4.  Muscle chloride channel dysfunction in two mouse models of myotonic dystrophy.

Authors:  John D Lueck; Ami Mankodi; Maurice S Swanson; Charles A Thornton; Robert T Dirksen
Journal:  J Gen Physiol       Date:  2006-12-11       Impact factor: 4.086

Review 5.  Clinical evaluation of membrane excitability in muscle channel disorders: potential applications in clinical trials.

Authors:  James C Cleland; Eric L Logigian
Journal:  Neurotherapeutics       Date:  2007-04       Impact factor: 7.620

6.  Novel muscle chloride channel mutations and their effects on heterozygous carriers.

Authors:  V Mailänder; R Heine; F Deymeer; F Lehmann-Horn
Journal:  Am J Hum Genet       Date:  1996-02       Impact factor: 11.025

7.  Spectrum of mutations in the major human skeletal muscle chloride channel gene (CLCN1) leading to myotonia.

Authors:  C Meyer-Kleine; K Steinmeyer; K Ricker; T J Jentsch; M C Koch
Journal:  Am J Hum Genet       Date:  1995-12       Impact factor: 11.025

8.  A case report of recessive myotonia congenita and early onset cognitive impairment: Is it a causal or casual link?

Authors:  Simona Portaro; Alberto Cacciola; Antonino Naro; Demetrio Milardi; Rosa Morabito; Francesco Corallo; Silvia Marino; Alessia Bramanti; Emanuela Mazzon; Rocco Salvatore Calabrò
Journal:  Medicine (Baltimore)       Date:  2018-06       Impact factor: 1.889

9.  Multimeric structure of ClC-1 chloride channel revealed by mutations in dominant myotonia congenita (Thomsen).

Authors:  K Steinmeyer; C Lorenz; M Pusch; M C Koch; T J Jentsch
Journal:  EMBO J       Date:  1994-02-15       Impact factor: 11.598

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.